Announce Date | 04/29/2025 |
EPS Normalized Actual | $0.93 (Beat by $0.07) |
EPS GAAP Actual | $0.93 (Beat by $0.07) |
Revenue Actual | $1.01036B |
Revenue Surprise | Beat by $1010.36M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.99 |
EPS GAAP Estimate | $0.99 |
Revenue Estimate | $1.1245B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2028 | 4.319 | 21.06 | 4.17025 | 4.47356 | 4 |
Mar 2027 | 4.6981 | 19.36 | 4.5363 | 4.86622 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 1.01036B | 2.97% | 1010.36M |
FQ4 2024 (Dec 2024) | 1.33 | 1.33 | 1.34029B | 6.33% | 1340.29M |
FQ3 2024 (Sep 2024) | 0.95 | 0.95 | 1.10944B | 4.73% | 1109.44M |
FQ2 2024 (Jun 2024) | 0.93 | 0.93 | 1.08822B | 10.45% | 1088.22M |
FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 0.980352B | 2.07% | 980.35M |
FQ4 2023 (Dec 2023) | 1.57 | 1.57 | 1.25547B | -1.15% | 1255.47M |
FQ3 2023 (Sep 2023) | 0.87 | 0.87 | 1.05701B | -8.7% | 1057.01M |
FQ2 2023 (Jun 2023) | 0.39 | 0.39 | 0.974499B | -19.02% | 974.5M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.99
Consensus Revenue Estimates
1.1245B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.8982 | -- | 1.53293 | 1.98061 | 1 |
FQ3 2027 (Sep 2027) | 1.4477 | -- | 1.16912 | 1.51055 | 1 |
FQ2 2027 (Jun 2027) | 1.392 | -- | 1.12414 | 1.45243 | 1 |
FQ1 2027 (Mar 2027) | 1.09 | -- | 1.06729 | 1.12152 | 2 |
FQ4 2026 (Oct 2026) | 1.2099 | -- | 1.1521 | 1.24743 | 3 |
FQ3 2026 (Jul 2026) | 1.0963 | -- | 1.04392 | 1.13031 | 3 |
FQ2 2026 (Jun 2026) | 1.0963 | -- | 1.05225 | 1.12725 | 1 |
FQ1 2026 (Mar 2026) | 0.95 | -2.11 | 0.8913 | 0.98511 | 3 |
FQ4 2025 (Oct 2025) | 1.14 | -16.67 | 1.08554 | 1.17537 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.54B | -- | 1.31B | 1.59B | 3 |
FQ3 2027 (Sep 2027) | 1.3B | -- | 1.11B | 1.34B | 3 |
FQ2 2027 (Jun 2027) | 1.25B | -- | 1.07B | 1.29B | 3 |
FQ1 2027 (Mar 2027) | 1.14B | -- | 1.12B | 1.17B | 4 |
FQ4 2026 (Oct 2026) | 1.25B | -- | 1.21B | 1.28B | 2 |
FQ3 2026 (Jul 2026) | 1.2B | -- | 1.16B | 1.23B | 2 |
FQ2 2026 (Jun 2026) | 1.2B | -- | 1.16B | 1.23B | 2 |
FQ1 2026 (Mar 2026) | 1.05B | 3.95 | 1B | 1.08B | 2 |
FQ4 2025 (Oct 2025) | 1.17B | -14.15 | 1.13B | 1.2B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 100% | |
FQ4 2024 (Dec 2024) | 1.33 | 1.33 | 100% | |
FQ3 2024 (Sep 2024) | 0.95 | 0.95 | 100% | |
FQ2 2024 (Jun 2024) | 0.93 | 0.93 | 100% | |
FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 100% | |
FQ4 2023 (Dec 2023) | 1.57 | 1.57 | 100% | |
FQ3 2023 (Sep 2023) | 0.87 | 0.87 | 100% | |
FQ2 2023 (Jun 2023) | 0.39 | 0.39 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.01B | $1010.36M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.34B | $1340.29M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.11B | $1109.44M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.09B | $1088.22M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.98B | $980.35M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.26B | $1255.47M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.06B | $1057.01M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.97B | $974.5M | 100% |